Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for JSR Life Sciences

    Client Virtual Booth

    JSR LIFE SCIENCES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    EXCIPIENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    JSR Life Sciences
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1280 N. Mathilda Avenue Sunnyvale, CA 94089
    Telephone
    Telephone
    +1 408 543 8800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.jsrlifesciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/jsrlifesciences/
    Twitter
    Twitter
    https://twitter.com/jsrlifesciences

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    JSR Life Sciences Announces Operational Consolidation of KBI Bio and Selexis
    JSR Life Sciences Announces Operational Consolidation of KBI Bio and Selexis

    https://www.businesswire.com/news/home/20230531005198/en

    BUSINESSWIRE
    31 May 2023
    Share Share
    Crown Bioscience Opens Singapore Lab, Partners with JSR Life Sciences
    Crown Bioscience Opens Singapore Lab, Partners with JSR Life Sciences

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-10/crown-bioscience-opens-singapore-lab-partners-with-jsr-life-sciences/?widget=listSection

    CONTRACT PHARMA
    10 Mar 2023
    Share Share
    Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs
    Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs

    https://www.contractpharma.com/contents/view_breaking-news/2023-02-15/similis-bio-partners-with-novel351k-to-develop-mul/

    CONTRACT PHARMA
    15 Feb 2023
    Share Share
    Crown Bioscience inks deal with ERS for gene editing technology
    Crown Bioscience inks deal with ERS for gene editing technology

    https://www.fiercebiotech.com/cro/crown-bioscience-inks-deal-ers-genomics-gene-editing-tech

    Joseph Keenan FIERCEBIOTECH
    12 Dec 2022
    Share Share
    JSR Life Sciences Launches 'Similis Bio' for Biosimilar Development
    JSR Life Sciences Launches 'Similis Bio' for Biosimilar Development

    https://www.businesswire.com/news/home/20220510005401/en

    BUSINESSWIRE
    10 May 2022
    Share Share
    JSR Life Sciences Appoints Mark W. Womack to Lead KBI Biopharma and Selexis SA
    JSR Life Sciences Appoints Mark W. Womack to Lead KBI Biopharma and Selexis SA

    https://www.businesswire.com/news/home/20220502005028/en

    BUSINESSWIRE
    02 May 2022
    Share Share
    KBI Biopharma Opens New Commercial Manufacturing Facility
    KBI Biopharma Opens New Commercial Manufacturing Facility

    https://www.contractpharma.com/contents/view_breaking-news/2022-04-21/kbi-biopharma-opens-new-commercial-manufacturing-facility/?widget=listSection

    CONTRACTPHARMA
    21 Apr 2022
    Share Share
    JSR Life Sciences’ Amsphere A3 Leveraged in FDA-Approved Antibody Therapy
    JSR Life Sciences’ Amsphere A3 Leveraged in FDA-Approved Antibody Therapy

    https://www.contractpharma.com/contents/view_breaking-news/2022-03-21/jsr-life-sciences-amsphere-a3-leveraged-in-fda-approved-antibody-therapy/

    CONTRACTPHARMA
    21 Mar 2022
    Share Share
    Hemogenyx, Selexis Will Advance AML CDX Bispecific Antibody to Human Trials
    Hemogenyx, Selexis Will Advance AML CDX Bispecific Antibody to Human Trials

    https://www.businesswire.com/news/home/20220112005112/en

    BUSINESSWIRE
    12 Jan 2022
    Share Share
    Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’
    Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’

    https://www.businesswire.com/news/home/20211007005565/en/Crown-Bioscience-Launches-%E2%80%983D-Ex-Vivo-Patient-Tissue-Platform%E2%80%99-to-Improve-Response-Predictability-to-Immuno-Oncology-Drug-Candidates

    BUSINESSWIRE
    07 Oct 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    fermion-oy-2024-05-13

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search